Insight
EDGAR Next: What Filers Should Know
by Niki Fang, Albert Vanderlaan and Bobby Bee | April.17.2025
Orrick's Capital Markets team addresses common questions for public companies regarding the SEC's new "EDGAR Next" rules.
Insight
First Lawsuit Filed Under Washington’s My Health My Data Act
by Thora Johnson, Sundeep Kapur, Emily S. Tabatabai, Aravind Swaminathan and Peter Graham | February.24.2025
On February 10, 2025, a Washington state resident filed a lawsuit against Amazon under the Washington My Health My Data Act.
Insight
Telehealth Transformation: Innovating Mental Health Care
Life Sciences Snapshot – Q1 2025
February.19.2025
U.S. life sciences VC rebounded in 2024 with rising deal and exit value. Orrick’s Life Sciences Snapshot breaks down the key trends.
Insight
Massachusetts Adopts Law to Regulate Domestic Money Transmission
January.10.2025
The new law is generally consistent with the Money Transmission Modernization Act (MTMA) and takes effect in September 2025.
Insight
FDA Issues Draft Guidance on AI-Enabled Medical Devices
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph | January.07.2025
The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices.
Insight
DEA Issues Third Extension of Telemedicine Prescribing Flexibilities
by Amy M. Joseph, Jeremy D. Sherer, Melania Jankowski and Anna Booth | January.02.2025
The Third Extension allows providers to continue prescribing controlled substances without a prior in-person examination through December 31, 2025.
Insight
Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends
December.20.2024
Healthtech Horizons: Navigating Regulation, Investment, and Strategy in a Transforming Market
Insight
Fifth Circuit Strikes Down Nasdaq Board Diversity Rules
by Albert Vanderlaan, Soo Hwang and Bobby Bee | December.18.2024
The U.S. Court of Appeals for the Fifth Circuit vacated the SEC’s approval of Nasdaq’s board diversity rules.
Insight
SEC Comment Letter Trend: AI-Related Disclosures
by Marsha Mogilevich, Albert Vanderlaan and Bobby Bee | December.12.2024
Orrick's summary of SEC disclosure comments surrounding the use of AI and key issues raised through its guidance & enforcement actions as of October ...
Insight
California Gov. Newsom Vetoes Controversial Frontier AI Bill as Non-Responsive to “Actual Risks”
by Jeremy Kudon, Shannon Yavorsky and Matthew E.S. Coleman | September.30.2024
California Gov. Gavin Newsom has vetoed SB 1047 – the controversial AI regulation bill that both chambers of the California legislature passed by ...
Insight
Navigating University Technology Licensing for Startups: Key Considerations
by Stephen Thau and David Sharrow | September.23.2024
Licensing university technology to start a company is complex. Founders should be aware of key challenges and opportunities in the process.
Insight
The EU AI Act: What Life Sciences and Digital Health Companies Should Know
by Julia Apostle, Daniel Kadin and David Sharrow | September.13.2024
EU AI Act is a landmark piece of legislation that establishes the first comprehensive framework for regulating the use of artificial intelligence.